Urethral cancer natural history, complications, and prognosis

Urethral cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Urethral cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Urethral cancer natural history, complications, and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Urethral cancer natural history, complications, and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Urethral cancer natural history, complications, and prognosis
CDC on Urethral cancer natural history, complications, and prognosis
Urethral cancer natural history, complications, and prognosis in the news
Blogs on Urethral cancer natural history, complications, and prognosis
Directions to Hospitals Treating Urethral cancer
Risk calculators and risk factors for Urethral cancer natural history, complications, and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The prognosis of urethral cancer varies with the depth of invasion, anatomical location, size, and stage of tumor. Superficial tumors located in the distal urethra have the most favorable prognosis.

Prognosis

• The prognosis of urethral cancer depends on the following factors:

• Anatomical location
• Size
• Stage
• Depth of invasion

• Superficial tumors located in the distal urethra of both the female and male are generally curable. However, deeply invasive lesions are rarely curable by any combination of therapies.
• In men, the prognosis of tumors in the distal (pendulous) urethra is better than for tumors of the proximal (bulbomembranous) and prostatic urethra, which tend to present at more advanced stages.
• Distal urethral tumors tend to occur at earlier stages in women, and they appear to have a better prognosis than proximal tumors.
• Lesions of the proximal or entire length of the urethra are usually associated with invasion and a high incidence of pelvic nodal metastases with 5-year survival rates ranging from 10% to 20%.